相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antibodies to watch in 2018
Helene Kaplon et al.
MABS (2018)
Structural characterization of the Man5 glycoform of human IgG3 Fc
Ishan S. Shah et al.
MOLECULAR IMMUNOLOGY (2017)
Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice
Rens Braster et al.
PLOS ONE (2017)
Immunogenicity of Therapeutic Protein Aggregates
Ehab M. Moussa et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3)
Rosina Plomp et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1
Lai Sum Leoh et al.
MOLECULAR IMMUNOLOGY (2015)
Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases
Vashti Irani et al.
MOLECULAR IMMUNOLOGY (2015)
Conformational and Colloidal Stabilities of Isolated Constant Domains of Human Immunoglobulin G and Their Impact on Antibody Aggregation under Acidic Conditions
Seiki Yageta et al.
MOLECULAR PHARMACEUTICS (2015)
Stability engineering of the human antibody repertoire
Romain Rouet et al.
FEBS LETTERS (2014)
Dynamics of Inter-heavy Chain Interactions in Human Immunoglobulin G (IgG) Subclasses Studied by Kinetic Fab Arm Exchange
Theo Rispens et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
Nicole L. Yates et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
IgG subclasses and allotypes: from structure to effector functions
Gestur Vidarsson et al.
FRONTIERS IN IMMUNOLOGY (2014)
An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels
Thies Roesner et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface
Alexey Teplyakov et al.
MOLECULAR IMMUNOLOGY (2013)
Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress
Takahiko Ito et al.
PROTEIN SCIENCE (2013)
Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies
Santosh V. Thakkar et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential
Nigel M. Stapleton et al.
NATURE COMMUNICATIONS (2011)
Acid-Induced Aggregation of Human Monoclonal IgG1 and IgG2: Molecular Mechanism and the Effect of Solution Composition
Sanjay B. Hari et al.
BIOCHEMISTRY (2010)
Aggregation-Prone Motifs in Human Immunoglobulin G
Naresh Chennamsetty et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Protein Aggregation: Pathways, Induction Factors and Analysis
Hanns-Christian Mahler et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Structural Difference in the Complement Activation Site of Human IgG1 and IgG3
T. E. Michaelsen et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
Engineered antibodies of IgG1/IgG3 mixed isotype with enhanced cytotoxic activities
Akito Natsume et al.
CANCER RESEARCH (2008)
Comparison of LC and LC/MS Methods for Quantifying N-Glycosylation in Recombinant IgGs
Sandipan Sinha et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2008)
Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies
Daisuke Ejima et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)
Protein aggregation and bioprocessing
Mary E. M. Cromwell et al.
AAPS JOURNAL (2006)
IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides
R Niwa et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density
R Niwa et al.
CLINICAL CANCER RESEARCH (2005)
Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 is independent of FcγRIIIa functional polymorphism
R Niwa et al.
CLINICAL CANCER RESEARCH (2004)
Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma
WK Weng et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Fcγ receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro
AE Tebo et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
X-ray crystallographic studies of IgG-Fcγ receptor interactions
P Sondermann et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2002)
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
G Cartron et al.
BLOOD (2002)
Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1
O Scharf et al.
JOURNAL OF VIROLOGY (2001)
Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc
EE Idusogie et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
